GeneMedix plans 2 more insulin projects


  • Business
  • Saturday, 14 Aug 2004

Britain-based bio-generic company, GeneMedix Plc, which will set up Asia's first human insulin plant here in 2005, is in negotiations to set up two more similar projects here. 

British High Commissioner in Malaysia Bruce Cleghorn said both the projects were currently under “commercial negotiations'' but declined to disclose the nature of the projects and the investment involved.  

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

KL Sentral Station redevelopment project to commence year-end - Loke
Malaysia's March manufacturing sales value grows 1.4% to RM158.4bil
Oil set for weekly gain as demand signs, geopolitics seen as positives
Asia stocks rally on renewed global rate cut optimism
Daiso invests RM1bil in new global distribution centre
IPI up 2.4% in March 2024 but below forecast
Malaysia end-April palm oil stocks rise 1.85%, MPOB says
FBM KLCI nearly flat at midday
UOB Malaysia's FY23 operating income hits record RM4.6bil, pretax profit RM1.9bil
Bursa Malaysia all-time high indicates Madani framework is building investor confidence

Others Also Read